State Street Corp Nuvation Bio Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Nuvation Bio Inc. stock. As of the latest transaction made, State Street Corp holds 4,166,441 shares of NUVB stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,166,441

Previous 3,975,410 4.81%

Holding current value

$11.7 Million

Previous $11.6 Million 17.45%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.3 - $3.83 $439,371 - $731,648	191,031 Added 4.81%	4,166,441 $9.58 Million
Q2 2024 Aug 14, 2024	BUY	$2.58 - $3.69 $2.4 Million - $3.44 Million	931,900 Added 30.62%	3,975,410 $11.6 Million
Q1 2024 May 15, 2024	SELL	$1.46 - $3.97 $27,307 - $74,254	-18,704 Reduced 0.61%	3,043,510 $11.1 Million
Q4 2023 Feb 14, 2024	BUY	$0.96 - $1.53 $31,746 - $50,595	33,069 Added 1.09%	3,062,214 $4.62 Million
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.1 $9,700 - $16,167	7,699 Added 0.25%	3,029,145 $4.06 Million
Q2 2023 Aug 14, 2023	BUY	$1.56 - $1.84 $355,740 - $419,591	228,039 Added 8.16%	3,021,446 $5.44 Million
Q1 2023 May 15, 2023	BUY	$1.6 - $2.48 $217,112 - $336,523	135,695 Added 5.11%	2,793,407 $4.64 Million
Q4 2022 Feb 14, 2023	SELL	$1.68 - $2.5 $693,312 - $1.03 Million	-412,686 Reduced 13.44%	2,657,712 $5.1 Million
Q3 2022 Nov 15, 2022	BUY	$0.29 - $4.04 $35,462 - $494,027	122,284 Added 4.15%	3,070,398 $6.88 Million
Q2 2022 Aug 15, 2022	SELL	$3.24 - $5.85 $157,894 - $285,088	-48,733 Reduced 1.63%	2,948,114 $9.55 Million
Q1 2022 May 16, 2022	BUY	$4.6 - $8.83 $1.21 Million - $2.32 Million	262,811 Added 9.61%	2,996,847 $15.8 Million
Q4 2021 Feb 14, 2022	BUY	$7.75 - $10.05 $10.3 Million - $13.4 Million	1,330,900 Added 94.85%	2,734,036 $23.2 Million
Q3 2021 Nov 15, 2021	BUY	$7.78 - $10.0 $3.75 Million - $4.83 Million	482,631 Added 52.43%	1,403,136 $13.9 Million
Q2 2021 Aug 16, 2021	BUY	$9.22 - $14.48 $8.1 Million - $12.7 Million	878,005 Added 2065.89%	920,505 $8.57 Million
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $382,500 - $619,225	42,500 New	42,500 $444,000

Others Institutions Holding NUVB

# of Institutions

158

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $613M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Nuvation Bio Inc. Transaction History